The largest database of trusted experimental protocols

Superose 12 hr10 30

Manufactured by GE Healthcare
Sourced in United States, Sweden

Superose 12 HR10/30 is a size exclusion chromatography column designed for high-resolution separation of macromolecules. It is composed of cross-linked agarose beads with a narrow pore size distribution, providing efficient separation of proteins, peptides, and other biomolecules based on their molecular size.

Automatically generated - may contain errors

5 protocols using superose 12 hr10 30

1

Protein Characterization by SAXS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sample was prepared according to Borko et al. (2013 ▶ ). The sample quality was tested by dynamic light scattering (DLS; Zetasizer Nano-S) and size-exclusion chromatography (SEC; GE ÄKTA FPLC, Superose 12 HR10/30) at 5–10°C. Prior to SAXS data collection the protein sample was diluted at ratios of 1:1, 1:2, 1:3, 1:4 and 1:5 with the sample buffer without detergents. The protein concentration during the measurement was in the range 2–10 mg ml−1. SAXS data were collected on beamline X33, DESY, Hamburg (see Supporting Information1 for beamline characteristics). The SAXS data were processed with programs from the ATSAS 2.5 package (Supplementary Fig. S1). Initial processing and analysis were performed with PRIMUS (Konarev et al., 2003 ▶ ). The radius of gyration (Rg) was estimated by Guinier approximation and from the pair-distribution function P(r). Information about the degree of protein disorder was obtained from the Kratky plot. The particle volume was calculated using the Porod invariant and the molecular weight was estimated from the Porod volume. Ab initio modelling was performed with GASBOR (Svergun et al., 2001 ▶ ) using ten repetitions with one scattering curve, with χ2 between 0.9 and 1. The normalized spatial discrepancy (NSD) of all models was compared using DAMSEL (Volkov & Svergun, 2003 ▶ ). The average NSD was 1.50 ± 0.07.
+ Open protocol
+ Expand
2

Xenopus laevis Oocyte Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Xenopus laevis adult females (Centre de Ressources Biologiques Xenopes, CNRS, France) were bred and maintained according to current French guidelines in the conventional IBPS aquatic animal facility, with authorization: Animal Facility Agreement: #A75-05-25. All experiments were subject to ethical review and approved by the French Ministry of Higher Education and Research (reference APAFIS#14127-2018031614373133v2).
All reagents, unless otherwise specified, were from Sigma. Okadaic acid (OA), magnetic GSH-beads and Co-beads were purchased from Enzo Life Sciences, Promega and Clontech Laboratories respectively. Uno Q-25 was purchased from Bio-Rad, Mono Q 4.6/100PE, Phenyl-Superose HR5/5 and Superose 12 HR10/30 were from GE Healthcare.
+ Open protocol
+ Expand
3

Analyzing Protease-Mediated PAN Fragmentation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In all, 0.4 mg/ml of PAN was mixed with increasing amounts of Trypsin (0–2 μg per 40 μl rxn), incubated for 1 h at room temperature in reaction buffer (50 mM Tris pH 7.5, 5% v/v glycerol), and reactions were quenched with the manufacturer's recommendation amounts (1:100) of Halt Protease Inhibitor Cocktail (Thermo Scientific). Samples were checked for CC-OB domain fragment via Native-PAGE, and samples containing CC-OB domain fragment were pooled and injected onto a size exclusion column (Superose 12 HR 10/30, GE). Immediately after elution, 1:100 Halt Protease Inhibitor Cocktail (Thermo Scientific) was added to each fraction. Peaks were analyzed via SDS-PAGE and Native-PAGE and Fraction 1 (containing near-full-length PAN) and Fraction 3 (containing CC-OB fragment) were pooled. Fractions 1 and 3 were incubated with either 1 mM DTT (reduced sample) or 1 mM TT (oxidized sample) for 1 h at room temperature. After desalting (as described above), samples were run on SDS-PAGE and visualized via silver stain (Pierce Silver Stain Kit, Thermo Scientific). Representative images from four independent experiments are shown.
+ Open protocol
+ Expand
4

Purification of Cry4Ba Toxin and DIII

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 65 kDa Cry4Ba active toxin was prepared from E. coli strain JM109 expressing the 130 kDa Cry4Ba-R203Q protoxin in which one trypsin-cleavage site at Arg203 was mutated to Gln, thus giving a 65 kDa activated toxin upon tryptic digestion, as described previously [48 ]. Toxin preparation was accomplished by proteolytic digestion of the protoxin pre-solubilized in carbonate buffer (50 mM Na2CO3/NaHCO3, pH 9.0) with trypsin (N-tosyl-L-phenylalanine chloromethyl ketone-treated, Sigma-Aldrich, Burlington, VT, USA) before being subjected to purification by size-exclusion FPLC (fast protein liquid chromatography using Superose®12, HR10/30, GE Healthcare Bio-Sciences, Piscataway, NJ, USA) as described previously [10 (link)].
For preparation of the 21 kDa DIII fragment, the cloned Cry4Ba–DIII truncate, which was over-expressed as a soluble form in E. coli strain JM109 under control of the lac promoter, was effectively purified by anion-exchange (Resource Q column, GE Healthcare Bio-Sciences, Piscataway, NJ, USA) and size-exclusion FPLC as described elsewhere [28 (link)]. Both purified proteins were analyzed by sodium dodecyl sulfate-(12% w/v) polyacrylamide gel electrophoresis (SDS-PAGE) prior to the quantification of protein concentrations using the Bradford microassay (Bio-Rad, Hercules, CA, USA).
+ Open protocol
+ Expand
5

Purification of Cry4Ba Active Toxin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 65-kDa Cry4Ba full-length active toxin was prepared from the 130-kDa Cry4Ba-R203Q mutant protoxin in which one trypsin-cleavage site at Arg203 was replaced with Gln, thus giving a 65-kDa activated toxin upon digestion with trypsin and retaining high larval toxicity as described elsewhere [9 ]. Toxin preparation was accomplished by digestion of the protoxin pre-solubilized in carbonate buffer (50 mM Na2CO3/NaHCO3, pH 9.0) with trypsin (N-tosyl-L-phenylalanine chloromethyl ketone-treated, Sigma-Aldrich, St. Louis, MO, USA) prior to purification by size-exclusion FPLC using Superose® 12, HR10/30 (GE Healthcare Bio-Sciences, Uppsala, Sweden) as described elsewhere [39 (link)]. Finally, the purified toxin was analyzed by sodium dodecyl sulfate-(12% w/v) polyacrylamide gel electrophoresis (SDS-PAGE) and its concentration was determined by Bradford microassay (Bio-Rad, Hercules, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!